2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow Repligen Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas RG1068 (synthetic human secretin) - Pancreatitis | Phase 3 | Completed | Repligen Corporation | 258 | 2008-03-01 | 2009-12-03 |
| Synthetic Human Secretin in Children With Autism RG1068 (Synthetic Human Secretin) - Autism | Phase 3 | Completed | Repligen Corporation | 2002-04-01 | 2005-08-05 | |
| Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction RG1068 (Synthetic Human Secretin) - Autism | Phase 3 | Terminated | Repligen Corporation | 2002-04-01 | 2005-11-21 |
Autistic Disorder (2) · Pancreatitis (1)
Secretin (3)
United States (1)